General amyloid inhibitors? A critical examination of the inhibition of IAPP amyloid formation by inositol stereoisomers

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Wang, Hui ^a   Raleigh, Daniel P ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLOID BETA PROTEIN; AMYLOID INHIBITOR; CHIROINOSITOL; EPIINOSITOL; INOSITOL; INOSITOL DERIVATIVE; POLYPHENOL; PROTEIN INHIBITOR; SCYLLOINOSITOL; UNCLASSIFIED DRUG; AMYLOID;

ARTICLE; DRUG DESIGN; DRUG MECHANISM; DRUG SCREENING; PROTEIN CONFORMATION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; MOLECULAR GENETICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINOSIS; STEREOISOMERISM;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID; DIABETES MELLITUS, TYPE 2; INOSITOL; ISLET AMYLOID POLYPEPTIDE; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN CONFORMATION; STEREOISOMERISM;

EID: 84907432723     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104023     Document Type: Article

References (47)

1. Sipe JD (1994) Amyloidosis. Crit Rev Clin Lab Sci 31: 325-354.
2. Vendruscolo M, Zurdo J, MacPhee CE, Dobson CM (2003) Protein folding and misfolding: a paradigm of self-assembly and regulation in complex biological systems. Philos Trans A Math Phys Eng Sci 361: 1205-1222.
3. Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, et al. (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci 84: 8628-8632.
4. Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH (1987) Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 127: 414-417.
5. Gedulin BR, Rink TJ, Young AA (1997) Dose-response for glucagonostatic effect of amylin in rats. Metabolism 46: 67-70.
6. Rushing PA, Hagan MM, Seeley RJ, Lutz TA, D'Alessio DA, et al. (2001) Inhibition of central amylin signaling increases food intake and body adiposity in rats. Endocrinology 142: 5035-5038.
7. Clementi G, Caruso A, Cutuli VMC, deBernardis E, Prato A, et al. (1996) Amylin given by central or peripheral routes decreases gastric emptying and intestinal transit in the rat. Experientia 52: 677-679.
8. Scherbaum WA (1998) The role of amylin in the physiology of glycemic control. Exp Clin Endocr Diab 106: 97-102.
9. Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, et al. (1988) Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res Clin Pract 9: 151-159.
10. Westermark P, Grimelius L (1973) The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Pathologica Microbiologica Scandinavica Section A Pathology 81A: 291-300.
11. Westermark P, Wilander E (1978) The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 15: 417-421.
12. Andersson A, Bohman S, Borg LA, Paulsson JF, Schultz SW, et al. (2008) Amyloid deposition in transplanted human pancreatic islets: a conceivable cause of their long-term failure. Exp Diabetes Res 2008: 562985.
13. Potter KJ, Abedini A, Marek P, Klimek AM, Butterworth S, et al. (2010) Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci USA 107: 4305-4310.
14. Lorenzo A, Razzaboni B, Weir GC, Yankner BA (1994) Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368: 756-760.
15. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, et al. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416: 507-511.
16. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, et al. (1998) Diffusible, nonfibrillar ligands derived from A beta(1-42) are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95: 6448-6453.
17. Bucciantini M, Calloni G, Chiti F, Formigli L, Nosi D, et al. (2004) Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem 279: 31374-31382.
18. Sciacca Michele FM, Kotler Samuel A, Brender Jeffrey R, Chen J, Lee D-k, et al. (2012) Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation. Biophys J 103: 702-710.
19. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489.
20. O'Nuallain B, Williams AD, Westermark P, Wetzel R (2004) Seeding specificity in amyloid growth induced by heterologous fibrils. J Biol Chem 279: 17490-17499.
21. Yan LM, Tatarek-Nossol M, Velkova A, Kazantzis A, Kapurniotu A (2006) Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis. Proc Natl Acad Sci USA 103: 2046-2051.
22. Abedini A, Meng FL, Raleigh DP (2007) A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor. J Am Chem Soc 129: 11300-11301.
23. Porat Y, Mazor Y, Efrat S, Gazit E (2004) Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions. Biochemistry 43: 14454-14462.
24. Mishra R, Bulic B, Sellin D, Jha S, Waldmann H, et al. (2008) Small-molecule inhibitors of islet amyloid polypeptide fibril formation. Angew Chem Int Ed 47: 4679-4682.
25. Meng FL, Raleigh DP, Abedini A (2010) Combination of kinetically selected inhibitors in trans leads to highly effective inhibition of amyloid formation. J Am Chem Soc 132: 14340-14342.
26. Meng F, Abedini A, Plesner A, Verchere CB, Raleigh DP (2010) The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. Biochemistry 49: 8127-8133.
27. Cao P, Raleigh DP (2012) Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols. Biochemistry 51: 2670-2683.
28. Noor H, Cao P, Raleigh DP (2012) Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers. Protein Sci 21: 373-382.
29. Yan LM, Velkova A, Tatarek-Nossol M, Rammes G, Sibaev A, et al. (2013) Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and Aβ40. Angew Chem Int Ed 52: 10378-10383.
30. Bieschke J, Russ J, Friedrich RP, Ehrnhoefer DE, Wobst H, et al. (2010) EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity. Proc Natl Acad Sci USA 107: 7710-7715.
31. Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, et al. (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15: 558-566.
32. Palhano FL, Lee J, Grimster NP, Kelly JW (2013) Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. J Am Chem Soc 135: 7503-7510.
33. Mishra R, Sellin D, Radovan D, Gohlke A, Winter R (2009) Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol. ChemBioChem 10: 445-449.
34. Ladiwala ARA, Lin JC, Bale SS, Marcelino-Cruz AM, Bhattacharya M, et al. (2010) Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Aβ into off-pathway conformers. J Biol Chem 285: 24228-24237.
35. Fisher SK, Novak JE, Agranoff BW (2002) Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem 82: 736-754.
36. Michaelis T, Helms G, Merboldt KD, Hanicke W, Bruhn H, et al. (1993) Identification of scyllo-inositol in proton NMR-spectra of human brain in vivo. NMR Biomed 6: 105-109.
37. McLaurin J, Franklin T, Chakrabartty A, Fraser PE (1998) Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest. J Mol Biol 278: 183-194.
38. McLaurin J, Golomb R, Jurewicz A, Antel JP, Fraser PE (2000) Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid β peptide and inhibit Aβ-induced toxicity. J Biol Chem 275: 18495-18502.
39. Sinha S, Du Z, Maiti P, Klärner F-G, Schrader T, et al. (2012) Comparison of three amyloid assembly inhibitors: the sugar scyllo-inositol, the polyphenol epigallocatechin gallate, and the molecular tweezer CLR01. Acs Chem Neurosci 3: 451-458.
40. Bleiholder C, Do TD, Wu C, Economou NJ, Bernstein SS, et al. (2013) Ion mobility spectrometry reveals the mechanism of amyloid formation of A beta(25-35) and its modulation by inhibitors at the molecular level: epigallocatechin gallate and scyllo-inositol. J Am Chem Soc 135: 16926-16937.
41. McLaurin J, Kierstead ME, Brown ME, Hawkes CA, Lambermon MHL, et al. (2006) Cyclohexanehexol inhibitors of A beta aggregation prevent and reverse Alzheimer phenotype in a mouse model. Nat Med 12: 801-808.
42. Young LM, Cao P, Raleigh DP, Ashcroft AE, Radford SE (2014) Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors. J Am Chem Soc 136: 660-670.
43. Abedini A, Raleigh DP (2005) Incorporation of pseudoproline derivatives allows the facile synthesis of human IAPP, a highly amyloidogenic and aggregation-prone polypeptide. Org Lett 7: 693-696.
44. Marek P, Woys AM, Sutton K, Zanni MT, Raleigh DP (2010) Efficient microwave-assisted synthesis of human islet amyloid polypeptide designed to facilitate the specific incorporation of labeled amino acids. Org Lett 12: 4848-4851.
45. Abedini A, Singh G, Raleigh DP (2006) Recovery and purification of highly aggregation-prone disulfide-containing peptides: application to islet amyloid polypeptide. Anal Biochem 351: 181-186.
46. Li G, Rauscher S, Baud S, Pomes R (2012) Binding of inositol stereoisomers to model amyloidogenic peptides. J Phys Chem B 116: 1111-1119.
47. Li G, Pomes R (2013) Binding mechanism of inositol stereoisomers to monomers and aggregates of A beta(16-22). J Phys Chem B 117: 6603-6613.